Glossopharyngeal neuralgia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:221098G52.1
Who is this for?
Show terms as
1FDA treatments1Active trials27Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Glossopharyngeal neuralgia (GPN), also known as Weisenburg syndrome or vagoglossopharyngeal neuralgia, is a rare pain disorder characterized by severe, paroxysmal episodes of sharp, stabbing, or electric shock-like pain in the areas innervated by the glossopharyngeal nerve (cranial nerve IX) and sometimes the vagus nerve (cranial nerve X). The pain typically affects the back of the throat, tonsillar region, base of the tongue, ear canal, and occasionally the angle of the jaw. Episodes are usually brief, lasting seconds to a few minutes, but can be excruciating. Pain attacks are commonly triggered by swallowing, chewing, talking, coughing, yawning, or touching the affected areas. In some cases, GPN can be associated with bradycardia, hypotension, or even syncope (fainting) and cardiac arrest due to involvement of the vagus nerve, a potentially life-threatening complication known as vagoglossopharyngeal neuralgia with syncope. The condition primarily affects the nervous system and can be classified as classical (idiopathic), where no structural cause is identified but neurovascular compression of the glossopharyngeal nerve root is often suspected, or secondary (symptomatic), where an identifiable lesion such as a tumor, vascular malformation, or elongated styloid process (Eagle syndrome) is present. GPN most commonly presents in adults, typically after the age of 40, and appears to be slightly more common in men. Treatment of glossopharyngeal neuralgia typically begins with pharmacological management using anticonvulsant medications such as carbamazepine or oxcarbazepine, which are often effective in reducing the frequency and severity of pain episodes. Gabapentin and pregabalin may also be used. For patients who do not respond adequately to medication or who experience intolerable side effects, surgical options are available, including microvascular decompression (MVD) of the glossopharyngeal nerve, which has shown high success rates, or rhizotomy (sectioning of the nerve). In cases with cardiac complications, a cardiac pacemaker may be considered as an adjunctive measure. Early diagnosis and appropriate management are important to prevent potentially dangerous cardiovascular complications.

Clinical phenotype terms— hover any for plain English:

Cranial nerve compressionHP:0001293Jaw claudicationHP:0030164Ear painHP:0030766Tongue painHP:0030811Episodic painHP:0032148Mandibular painHP:0200025Abnormal glossopharyngeal nerve morphologyHP:3000047Vocal cord paralysisHP:0001605Vascular dilatationHP:0002617
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
May 2025Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)

Beijing Tiantan Hospital

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

CARBAMAZEPINE

CARBAMAZEPINE· Alembic Pharmaceuticals Inc.■ Boxed Warning

Beneficial results have also been reported in glossopharyngeal neuralgia

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)
Actively Recruiting
· Sites: Beijing, Beijing Municipality · Age: 1899 yrs

Specialists

Showing 25 of 27View all specialists →
AV
Ashwin Viswanathan
HOUSTON, TX
Specialist
1 Glossopharyngeal neuralgia publication
AM
Ali Mortezaei
Specialist
2 Glossopharyngeal neuralgia publications
MH
Mohammad Amin Habibi
ORANGE, CA
Specialist
2 Glossopharyngeal neuralgia publications
ZW
Zeyu Wu
Specialist
2 Glossopharyngeal neuralgia publications
YF
Yiyue Fan
Specialist
2 Glossopharyngeal neuralgia publications
YY
Ying Yang
Specialist
2 Glossopharyngeal neuralgia publications
AA
Anthony K Allam
Specialist
1 Glossopharyngeal neuralgia publication
ML
M Benjamin Larkin
Specialist
1 Glossopharyngeal neuralgia publication
HS
Himanshu Sharma
Specialist
1 Glossopharyngeal neuralgia publication
JP
Jae Sung Park
Specialist
1 Glossopharyngeal neuralgia publication
YA
Young Hwan Ahn
Specialist
1 Glossopharyngeal neuralgia publication
AH
Andrew Han
Specialist
1 Glossopharyngeal neuralgia publication
CM
Carver Montgomery
JACKSON, MS
Specialist
1 Glossopharyngeal neuralgia publication
BH
Bardia Hajikarimloo
Specialist
2 Glossopharyngeal neuralgia publications
IM
Ibrahim Mohammadzadeh
Specialist
2 Glossopharyngeal neuralgia publications
SM
Sweta Sengupta, MD
ORMOND BEACH, FL
Specialist
PI on 1 active trial
RP
Rudolf Likar, Prof.
Specialist
PI on 1 active trial
CT
Chao Tang
Specialist
2 Glossopharyngeal neuralgia publications
GZ
Gang Zhang
ST LOUIS PARK, MN
Specialist
2 Glossopharyngeal neuralgia publications
XT
Xiaorong Tan
Specialist
2 Glossopharyngeal neuralgia publications
NW
Nan Wu
Specialist
2 Glossopharyngeal neuralgia publications
JL
Jiang Liu
Specialist
2 Glossopharyngeal neuralgia publications
PW
Pan Wang
BROOKLYN, NY
Specialist
2 Glossopharyngeal neuralgia publications
JL
John Y K Lee
PA
Specialist
2 Glossopharyngeal neuralgia publications
HJ
Haotian Jiang
Specialist
2 Glossopharyngeal neuralgia publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Glossopharyngeal neuralgia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Glossopharyngeal neuralgiaForum →

No community posts yet. Be the first to share your experience with Glossopharyngeal neuralgia.

Start the conversation →

Latest news about Glossopharyngeal neuralgia

No recent news articles for Glossopharyngeal neuralgia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Glossopharyngeal neuralgia

What is Glossopharyngeal neuralgia?

Glossopharyngeal neuralgia (GPN), also known as Weisenburg syndrome or vagoglossopharyngeal neuralgia, is a rare pain disorder characterized by severe, paroxysmal episodes of sharp, stabbing, or electric shock-like pain in the areas innervated by the glossopharyngeal nerve (cranial nerve IX) and sometimes the vagus nerve (cranial nerve X). The pain typically affects the back of the throat, tonsillar region, base of the tongue, ear canal, and occasionally the angle of the jaw. Episodes are usually brief, lasting seconds to a few minutes, but can be excruciating. Pain attacks are commonly trigge

How is Glossopharyngeal neuralgia inherited?

Glossopharyngeal neuralgia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Glossopharyngeal neuralgia typically begin?

Typical onset of Glossopharyngeal neuralgia is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Glossopharyngeal neuralgia?

Yes — 1 recruiting clinical trial is currently listed for Glossopharyngeal neuralgia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Glossopharyngeal neuralgia?

25 specialists and care centers treating Glossopharyngeal neuralgia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.